JPRN-UMIN000002636CompletedPhase 1
Phase I/II trial of neoadjuvant chemotherapy with cisplatin and weekly paclitaxel in patients with stage Ib2- IIb uterine cervical cancer - Neoadjuvant chemotherapy with cisplatin and weekly paclitaxel in patients with cervical cancer
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Hyogo Cancer Center
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 75years-old (—)
- Sex
- Female
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) Usage of other experimental drugs, phenytoin or flucytosine 2) History of serious drug allergy or hypersensitivity with cisplatin or paclitaxel 3) Massive ascites 4) Active infection 5) Peripheral neuropathy 6) Unstable angina, myocardinal infarction within 6 months or serious arrthymia 7) Ileus 8) Interstitial pneumonia or fibrosis 9) Double cancer 10)No coexisting severe medical conditions such as uncontrollable diabetes mellitus, hypertension or bleeding 11) Pregnancy or lactation 12) Mental disease 13) Continuus usage of steroid 14) Bilateral hydronephrosis 15) Judged as inappropriate to participate this trial by investigators
Investigators
Similar Trials
Recruiting
Phase 1
Phase I/II trial of neoadjuvant chemotherapy with UFT/Leucovorin and Irinotecan plus radiation in patients with locally advanced rectal cancer.ocally advanced rectal cancer with preoperative diagnosis of T3-4 and N0-3.JPRN-UMIN000006208The University of Tokyo Hospital. Department of surgical oncology.39
Unknown
Phase 2
A Phase II trial of neoadjuvant chemotherapy with S-1 and fractional cisplatin for locally advanced gastric cancerGastric cancerJPRN-UMIN000001777Division of Biological Regulation and Oncology, Department of Surgery, Graduate School of Medicine, Tohoku University25
Recruiting
Phase 2
A phase II trial of neoadjuvant chemotherapy using the combination of gemcitabine and cisplatin for patients with initially unresectable locally advanced biliary tract cancer.Biliary tract cancer (Intrahepatic cholangiocarcinoma, Extrahepatic cholangiocarcinoma, Gallbladder carcinoma)JPRN-UMIN000015330Adjuvant therapy for BTC Research Group50
Recruiting
Not Applicable
A phase II trial of neoadjuvant chemotherapy with docetaxel,cisplatin and S-1 (DCS) for radically resectable advanced gastric carcinoma (KDOG 1001)radically resectable advanced gastric carcinomaJPRN-UMIN000003642Kitasato University School of Medicine40
Recruiting
Phase 1
Phase I, II study of neoadjuvant chemotherapy with gemcitabine and nab-paclitaxel for resectable pancreatic cancerpancreatic ductal cancerJPRN-jRCTs021200003Ishido Keinosuke30